MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today announced the appointment of Melanie I. Nallicheri as Senior Vice President, Corporate Development, Cell Therapies. In her role, Ms. Nallicheri is responsible for overall strategic planning, development of business plans, product/market competitive analyses and commercialization strategies, asset acquisition opportunities and pharmaceutical company alliances for Geron’s cell therapy programs. She reports to David L. Greenwood, Geron’s President and Chief Executive Officer.
